OSIRIS THERAPEUTICS INC NEW - COM (OSIR)

CUSIP: 68827R108

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM
Total 13F shares
8,500,953
Share change
-148,615
Total reported value
$132,772,726
Put/Call ratio
307%
Price per share
$15.62
Number of holders
67
Value change
-$2,193,847
Number of buys
31
Number of sells
30

Quarterly Holders Quick Answers

What is CUSIP 68827R108?
CUSIP 68827R108 identifies OSIR - OSIRIS THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OSIRIS THERAPEUTICS INC NEW - COM (OSIR) as of Q2 2014

As of 30 Jun 2014, OSIRIS THERAPEUTICS INC NEW - COM (OSIR) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,500,953 shares. The largest 10 holders included FMR LLC, Consonance Capital Management LP, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, State Street Corp, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 67 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.